オプションチェーンは、Stoke Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Stoke Therapeuticsの市場センチメントを評価します。.

Stoke Therapeutics (NASDAQ:STOK) 株価情報, オプションチェーン

Stoke Therapeutics

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

Stoke Therapeutics Inc

RBC Capital analyst Sam Crittenden reiterates Capstone Copper (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CS#TSX">CS</a>) with a Outperform and maintains C$12 price target.

News

Price Target

Reiteration

Analyst Ratings

TSX:CS

RBC Capital Reiterates Outperform on Capstone Copper, Maintains C$12 Price Target

Unum Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>) has outperformed the market over the past 5 years by 7.91% on an annualized basis producing an average annual return of 20.39%. Currently, Unum Gr has a market capitalization of $13.32 billion. 
Buying $1000 In UNM: If an investor had bought $1000 of UNM stock 5 years ago, it would be worth $2,512.92 today based on a price of $72.95 for UNM at the time of writing.
<h3>Unum Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736435709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Unum Gr 5 Years Ago Would Be Worth This Much Today

On Thursday, Nokia Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) disclosed that Openreach has selected its One Network Platform to build an open-<a target="_blank" href="https://www.globenewswire.com/news-release/2025/01/09/3006821/0/en/Nokia-and-Openreach-introduce-intent-based-networking-to-build-an-open-access-network-accelerating-UK-fiber-broadband-rollout.html" rel="noreferrer noopener">access </a>fiber network across the U.K.
Nokia&#8217;s solution is projected to enable Openreach to build a large-scale, multi-service network with lower power and space requirements. The architecture supports various deployment models, ensuring providers can seamlessly connect users to Openreach&#8217;s fiber network.
Notably, Openreach&#8217;s broadband network connects users to around 300 providers, offering high-speed fiber services in cities, towns, villages, and remote areas across the U.K.
Nokia&#8217;s One Network Platform helps meet the growing demand by offering flexibility and scale, while reducing the number of exchange buildings needed.
Built using Nokia&#8217;s One Network Platform, the network will enable Openreach to achieve its goal of connecting 25 million premises by the close of 2026, addressing the growing demand for high-speed broadband.
Using Nokia&#8217;s Altiplano and NSP network controllers, Openreach can automate fiber connectivity and simplify operations with a unified service interface and reduces OSS complexity by 85%, while providing real-time telemetry for better network performance insights.
Last week, Nokia, along with Intuitive Machines, Inc., successfully integrated the Lunar Surface Communication System into <a target="_blank" href="https://www.benzinga.com/25/01/42856421/from-earth-to-the-moon-intuitive-machines-and-nokia-launch-4glte-network" rel="noreferrer noopener">the&nbsp;IM-2 mission lander, Athena</a>.
Investors can gain exposure to NOK stock via&nbsp;iShares U.S. Digital Infrastructure and Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDGT#NYSE">IDGT</a>) and&nbsp;First Trust Indxx NextG ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTG#NASDAQ">NXTG</a>).
Price Action: NOK shares closed higher by 0.65% at $4.66 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/24/12/42535215/nokia-supercharges-indias-broadband-with-ishan-tech-taps-zscaler-to-upgrade-cloud-protection" target="_blank" rel="noreferrer noopener">Nokia Supercharges India&#8217;s Broadband with Ishan Tech; Taps Zscaler To Upgrade Cloud Protection</a></li>
</ul>

Equities

IDGT

NXTG

Openreach Taps Nokia For UK Fiber Expansion: Details

RBC Capital analyst Darko Mihelic upgrades Canadian Imperial Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CM#TSX">CM</a>) from Sector Perform to Outperform and raises the price target from C$97 to C$103.

Upgrades

TSX:CM

RBC Capital Upgrades Canadian Imperial Bank to Outperform, Raises Price Target to C$103

RBC Capital analyst Darko Mihelic upgrades Canadian Imperial Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CM#NYSE">CM</a>) from Sector Perform to Outperform and raises the price target from $97 to $103.

RBC Capital Upgrades Canadian Imperial Bank to Outperform, Raises Price Target to $103

RBC Capital analyst Darko Mihelic upgrades Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) from Sector Perform to Outperform and raises the price target from $133 to $161.

RBC Capital Upgrades Bank of Montreal to Outperform, Raises Price Target to $161

RBC Capital analyst Darko Mihelic upgrades Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) from Sector Perform to Outperform and raises the price target from C$133 to C$161.

TSX:BMO

RBC Capital Upgrades Bank of Montreal to Outperform, Raises Price Target to C$161

General

Real Estate

NMRK

Newmark Group Has Arranged The $360M Sale Of Two Park Avenue In Manhattan. The Transaction Is The Largest Advisor-led, All-office Property Sale In New York City In 2024

ARCH

CEIX

Arch Resources, CONSOL Energy Stockholders Vote To Approve All Proposals In Relation To Pending Combination

Treatment with ECUR-506 resulted in a complete clinical response from three months post exposure to the end of study (six months post exposure)
- ECUR-506 was generally well tolerated with no significant clinical safety concerns
- Insertion of a functional OTC gene through ARCUS in vivo gene editing may provide lasting clinical benefit for children with OTC deficiency who are in dire need of effective treatments

Biotech

Health Care

DTIL

Precision Biosciences' Partner iECURE Has Reported Clinical Efficacy And Safety Data In The First Patient Dosed With ECUR-506 In The Phase 1/2 OTC-HOPE Study

Revealing a significant insider sell on January 8, Randall K Fields, Chief Executive Officer at ReposiTrak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRAK#NYSE">TRAK</a>), as per the latest SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000050471/000141588925001112//Archives/edgar/data/50471/000141588925001112/0001415889-25-001112-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Fields sold 7,500 shares of ReposiTrak. The total transaction amounted to $162,059. 
During Thursday's morning session, ReposiTrak shares up by 0.09%, currently priced at $21.22.
<h3>Get to Know ReposiTrak Better</h3>
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
<h3>A Deep Dive into ReposiTrak's Financials</h3>
Positive Revenue Trend: Examining ReposiTrak's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.53% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 84.21%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): ReposiTrak's EPS reflects a decline, falling below the industry average with a current EPS of 0.09.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 70.73 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 19.35 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): ReposiTrak's EV/EBITDA ratio stands at 45.73, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Important Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000050471">Check Out The Full List Of ReposiTrak's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

TRAK

Insider Unloading: Randall K Fields Sells $162K Worth Of ReposiTrak Shares

In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we will perform a comprehensive industry comparison, evaluating UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) against its key competitors in the Health Care Providers &amp; Services industry. By analyzing important financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>UnitedHealth Group Background</h3>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>UnitedHealth Group Inc</td>
<td>34.10</td>
<td>5.11</td>
<td>1.25</td>
<td>6.59%</td>
<td>$9.73</td>
<td>$21.39</td>
<td>8.55%</td>
</tr>
<tr>
<td>Molina Healthcare Inc</td>
<td>15.21</td>
<td>3.59</td>
<td>0.44</td>
<td>6.78%</td>
<td>$0.51</td>
<td>$1.19</td>
<td>20.96%</td>
</tr>
<tr>
<td>Progyny Inc</td>
<td>30.42</td>
<td>3.57</td>
<td>1.56</td>
<td>2.34%</td>
<td>$0.01</td>
<td>$0.06</td>
<td>2.04%</td>
</tr>
<tr>
<td>Average</td>
<td>22.82</td>
<td>3.58</td>
<td>1.0</td>
<td>4.56%</td>
<td>$0.26</td>
<td>$0.62</td>
<td>11.5%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By conducting an in-depth analysis of UnitedHealth Group, we can identify the following trends: 
<ul>
<li>
The Price to Earnings ratio of 34.1 for this company is 1.49x above the industry average, indicating a premium valuation associated with the stock.
</li>
<li>
The elevated Price to Book ratio of 5.11 relative to the industry average by 1.43x suggests company might be overvalued based on its book value.
</li>
<li>
With a relatively high Price to Sales ratio of 1.25, which is 1.25x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
The company has a higher Return on Equity (ROE) of 6.59%, which is 2.03% above the industry average. This suggests efficient use of equity to generate profits and demonstrates profitability and growth potential.
</li>
<li>
The company exhibits higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $9.73 Billion, which is 37.42x above the industry average, implying stronger profitability and robust cash flow generation.
</li>
<li>
With higher gross profit of $21.39 Billion, which indicates 34.5x above the industry average, the company demonstrates stronger profitability and higher earnings from its core operations.
</li>
<li>
The company is witnessing a substantial decline in revenue growth, with a rate of 8.55% compared to the industry average of 11.5%, which indicates a challenging sales environment.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434858_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio provides insights into the proportion of debt a company has in relation to its equity and asset value.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In light of the Debt-to-Equity ratio, a comparison between UnitedHealth Group and its top 4 peers reveals the following information:
<ul>
<li>
Among its top 4 peers, UnitedHealth Group has a higher debt-to-equity ratio of 0.83.
</li>
<li>
This suggests a greater reliance on debt financing, which can expose the company to increased financial risk and potential volatility.
</li>
</ul>
<h3>Key Takeaways</h3>
For UnitedHealth Group, the PE, PB, and PS ratios are all high compared to its peers in the Health Care Providers &amp; Services industry, indicating potentially overvalued stock. On the other hand, the high ROE, EBITDA, and gross profit suggest strong profitability and operational efficiency. However, the low revenue growth rate may raise concerns about the company's future performance relative to its industry competitors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Markets

Evaluating UnitedHealth Group Against Peers In Health Care Providers &amp; Services Industry

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) in comparison to its major competitors within the Automobiles industry. By analyzing critical financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.
<h3>Tesla Background</h3>
Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and a robotaxi. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tesla Inc</td>
<td>108.20</td>
<td>18.13</td>
<td>14.19</td>
<td>3.18%</td>
<td>$4.22</td>
<td>$5.0</td>
<td>7.85%</td>
</tr>
<tr>
<td>Toyota Motor Corp</td>
<td>9.62</td>
<td>1.16</td>
<td>0.88</td>
<td>1.64%</td>
<td>$1449.68</td>
<td>$2438.49</td>
<td>0.09%</td>
</tr>
<tr>
<td>Thor Industries Inc</td>
<td>24.29</td>
<td>1.25</td>
<td>0.53</td>
<td>-0.05%</td>
<td>$0.08</td>
<td>$0.28</td>
<td>-14.31%</td>
</tr>
<tr>
<td>Average</td>
<td>16.95</td>
<td>1.21</td>
<td>0.71</td>
<td>0.79%</td>
<td>$724.88</td>
<td>$1219.38</td>
<td>-7.11%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>Through a meticulous analysis of Tesla, we can observe the following trends: 
<ul>
<li>
The current Price to Earnings ratio of 108.2 is 6.38x higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
It could be trading at a premium in relation to its book value, as indicated by its Price to Book ratio of 18.13 which exceeds the industry average by 14.98x.
</li>
<li>
With a relatively high Price to Sales ratio of 14.19, which is 19.99x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
With a Return on Equity (ROE) of 3.18% that is 2.39% above the industry average, it appears that the company exhibits efficient use of equity to generate profits.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $4.22 Billion is 0.01x below the industry average, suggesting potential lower profitability or financial challenges.
</li>
<li>
The company has lower gross profit of $5.0 Billion, which indicates 0.0x below the industry average. This potentially indicates lower revenue after accounting for production costs.
</li>
<li>
With a revenue growth of 7.85%, which surpasses the industry average of -7.11%, the company is demonstrating robust sales expansion and gaining market share.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434838_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio indicates the proportion of debt and equity used by a company to finance its assets and operations.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By evaluating Tesla against its top 4 peers in terms of the Debt-to-Equity ratio, the following observations arise:
<ul>
<li>
Tesla falls in the middle of the list when considering the debt-to-equity ratio.
</li>
<li>
This indicates that the company has a moderate level of debt relative to its equity with a debt-to-equity ratio of 0.18, suggesting a balanced financial structure with a reasonable debt-equitymix.
</li>
</ul>
<h3>Key Takeaways</h3>
For Tesla, the PE, PB, and PS ratios are all high compared to industry peers, indicating a potentially overvalued stock. On the other hand, Tesla's high ROE and revenue growth suggest strong performance and market potential. However, the low EBITDA and gross profit figures may raise concerns about operational efficiency and profitability compared to competitors in the Automobiles industry.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TSLA

Insights Into Tesla's Performance Versus Peers In Automobiles Sector

In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) alongside its primary competitors in the Interactive Media &amp; Services industry. By meticulously examining key financial metrics, market positioning, and growth prospects, we aim to offer valuable insights to investors and shed light on company's performance within the industry.
<h3>Meta Platforms Background</h3>
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Platforms Inc</td>
<td>28.82</td>
<td>9.37</td>
<td>10.25</td>
<td>9.77%</td>
<td>$22.06</td>
<td>$33.21</td>
<td>18.87%</td>
</tr>
<tr>
<td>Pinterest Inc</td>
<td>96.47</td>
<td>7.21</td>
<td>6.18</td>
<td>1.0%</td>
<td>$-0.0</td>
<td>$0.71</td>
<td>17.71%</td>
</tr>
<tr>
<td>ZoomInfo Technologies Inc</td>
<td>320.33</td>
<td>1.98</td>
<td>2.94</td>
<td>1.35%</td>
<td>$0.07</td>
<td>$0.26</td>
<td>-3.25%</td>
</tr>
<tr>
<td>Yelp Inc</td>
<td>23.79</td>
<td>3.47</td>
<td>2.02</td>
<td>5.21%</td>
<td>$0.06</td>
<td>$0.33</td>
<td>4.41%</td>
</tr>
<tr>
<td>Ziff Davis Inc</td>
<td>39.08</td>
<td>1.28</td>
<td>1.72</td>
<td>-2.68%</td>
<td>$0.02</td>
<td>$0.3</td>
<td>3.69%</td>
</tr>
<tr>
<td>JOYY Inc</td>
<td>11.90</td>
<td>0.40</td>
<td>1.09</td>
<td>1.17%</td>
<td>$0.06</td>
<td>$0.21</td>
<td>-1.48%</td>
</tr>
<tr>
<td>Weibo Corp</td>
<td>6.25</td>
<td>0.62</td>
<td>1.35</td>
<td>3.78%</td>
<td>$0.14</td>
<td>$0.37</td>
<td>5.05%</td>
</tr>
<tr>
<td>Tripadvisor Inc</td>
<td>58</td>
<td>2.23</td>
<td>1.24</td>
<td>4.33%</td>
<td>$0.1</td>
<td>$0.48</td>
<td>-0.19%</td>
</tr>
<tr>
<td>Average</td>
<td>79.4</td>
<td>2.46</td>
<td>2.36</td>
<td>2.02%</td>
<td>$0.06</td>
<td>$0.38</td>
<td>3.71%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>Through an analysis of Meta Platforms, we can infer the following trends: 
<ul>
<li>
The Price to Earnings ratio of 28.82 is 0.36x lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
With a Price to Book ratio of 9.37, which is 3.81x the industry average, Meta Platforms might be considered overvalued in terms of its book value, as it is trading at a higher multiple compared to its industry peers.
</li>
<li>
With a relatively high Price to Sales ratio of 10.25, which is 4.34x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
With a Return on Equity (ROE) of 9.77% that is 7.75% above the industry average, it appears that the company exhibits efficient use of equity to generate profits.
</li>
<li>
With higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $22.06 Billion, which is 367.67x above the industry average, the company demonstrates stronger profitability and robust cash flow generation.
</li>
<li>
The company has higher gross profit of $33.21 Billion, which indicates 87.39x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of 18.87% exceeds the industry average of 3.71%, indicating strong sales performance and market outperformance.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434827_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio assesses the extent to which a company relies on borrowed funds compared to its equity.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In terms of the Debt-to-Equity ratio, Meta Platforms can be assessed by comparing it to its top 4 peers, resulting in the following observations:
<ul>
<li>
In terms of the debt-to-equity ratio, Meta Platforms has a lower level of debt compared to its top 4 peers, indicating a stronger financial position.
</li>
<li>
This implies that the company relies less on debt financing and has a more favorable balance between debt and equity with a lower debt-to-equity ratio of 0.3.
</li>
</ul>
<h3>Key Takeaways</h3>
For Meta Platforms, the PE ratio is low compared to peers, indicating potential undervaluation. The high PB and PS ratios suggest the market values the company's assets and sales highly. In terms of ROE, EBITDA, gross profit, and revenue growth, Meta Platforms outperforms its industry peers, reflecting strong financial performance and growth potential.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comparative Study: Meta Platforms And Industry Competitors In Interactive Media &amp; Services Industry

eBay's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NYSE">EBAY</a>) short percent of float has fallen 6.2% since its last report. The company recently reported that it has 20.91 million shares sold short, which is 4.99% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>eBay Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434823_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for eBay has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing eBay's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, eBay's peer group average for short interest as a percentage of float is 10.33%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

EBAY

Peering Into eBay's Recent Short Interest

In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) in comparison to its major competitors within the Software industry. By analyzing crucial financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.
<h3>Microsoft Background</h3>
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microsoft Corp</td>
<td>35.06</td>
<td>10.97</td>
<td>12.48</td>
<td>8.87%</td>
<td>$38.23</td>
<td>$45.49</td>
<td>16.04%</td>
</tr>
<tr>
<td>Oracle Corp</td>
<td>39.89</td>
<td>33.19</td>
<td>8.44</td>
<td>25.66%</td>
<td>$5.75</td>
<td>$9.97</td>
<td>8.64%</td>
</tr>
<tr>
<td>ServiceNow Inc</td>
<td>163.41</td>
<td>23.30</td>
<td>20.82</td>
<td>4.81%</td>
<td>$0.67</td>
<td>$2.21</td>
<td>22.25%</td>
</tr>
<tr>
<td>Palo Alto Networks Inc</td>
<td>44.83</td>
<td>19.18</td>
<td>14.81</td>
<td>6.33%</td>
<td>$0.45</td>
<td>$1.58</td>
<td>13.88%</td>
</tr>
<tr>
<td>Monday.Com Ltd</td>
<td>528.79</td>
<td>11.67</td>
<td>12.89</td>
<td>-1.28%</td>
<td>$-0.02</td>
<td>$0.23</td>
<td>32.67%</td>
</tr>
<tr>
<td>QXO Inc</td>
<td>26.81</td>
<td>1.38</td>
<td>24.42</td>
<td>-0.21%</td>
<td>$-0.03</td>
<td>$0.01</td>
<td>-2.0%</td>
</tr>
<tr>
<td>Qualys Inc</td>
<td>29.67</td>
<td>10.94</td>
<td>8.51</td>
<td>10.53%</td>
<td>$0.05</td>
<td>$0.13</td>
<td>8.36%</td>
</tr>
<tr>
<td>Teradata Corp</td>
<td>36.61</td>
<td>23.83</td>
<td>1.71</td>
<td>32.0%</td>
<td>$0.08</td>
<td>$0.27</td>
<td>0.46%</td>
</tr>
<tr>
<td>Progress Software Corp</td>
<td>34.05</td>
<td>6.38</td>
<td>3.93</td>
<td>6.88%</td>
<td>$0.06</td>
<td>$0.15</td>
<td>2.11%</td>
</tr>
<tr>
<td>SolarWinds Corp</td>
<td>63.91</td>
<td>1.76</td>
<td>3.07</td>
<td>0.94%</td>
<td>$0.07</td>
<td>$0.18</td>
<td>5.5%</td>
</tr>
<tr>
<td>Average</td>
<td>107.55</td>
<td>14.63</td>
<td>10.96</td>
<td>9.52%</td>
<td>$0.79</td>
<td>$1.64</td>
<td>10.21%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By carefully studying Microsoft, we can deduce the following trends: 
<ul>
<li>
With a Price to Earnings ratio of 35.06, which is 0.33x less than the industry average, the stock shows potential for growth at a reasonable price, making it an interesting consideration for market participants.
</li>
<li>
With a Price to Book ratio of 10.97, significantly falling below the industry average by 0.75x, it suggests undervaluation and the possibility of untapped growth prospects.
</li>
<li>
With a relatively high Price to Sales ratio of 12.48, which is 1.14x the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
With a Return on Equity (ROE) of 8.87% that is 0.65% below the industry average, it appears that the company exhibits potential inefficiency in utilizing equity to generate profits.
</li>
<li>
The company exhibits higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $38.23 Billion, which is 48.39x above the industry average, implying stronger profitability and robust cash flow generation.
</li>
<li>
The gross profit of $45.49 Billion is 27.74x above that of its industry, highlighting stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of 16.04% is notably higher compared to the industry average of 10.21%, showcasing exceptional sales performance and strong demand for its products or services.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434818_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio gauges the extent to which a company has financed its operations through debt relative to equity.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When evaluating Microsoft alongside its top 4 peers in terms of the Debt-to-Equity ratio, the following insights arise:
<ul>
<li>
When considering the debt-to-equity ratio, Microsoft exhibits a stronger financial position compared to its top 4 peers.
</li>
<li>
This indicates that the company has a favorable balance between debt and equity, with a lower debt-to-equity ratio of 0.21, which can be perceived as a positive aspect by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
The low PE and PB ratios suggest that Microsoft is undervalued compared to its peers in the Software industry. However, the high PS ratio indicates that the market values Microsoft's revenue more highly. In terms of ROE, EBITDA, gross profit, and revenue growth, Microsoft demonstrates strong performance relative to its industry competitors, reflecting its efficient operations and growth potential.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSFT

Inquiry Into Microsoft's Competitor Dynamics In Software Industry

Civeo's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVEO#NYSE">CVEO</a>) short percent of float has fallen 13.33% since its last report. The company recently reported that it has 61 thousand shares sold short, which is 0.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Civeo Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434818_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Civeo has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Civeo's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Civeo's peer group average for short interest as a percentage of float is 4.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CVEO

(CVEO) - Analyzing Civeo's Short Interest

Wall Street investors are betting heavily <a href="https://www.benzinga.com/25/01/42813324/trumps-universal-tariff-plans-take-shape-analysts-expect-stronger-for-longer-greenback">on a strong U.S. dollar during Trump&#8217;s second term</a>, even as uncertainty looms over his proposed economic policies.
Currency traders have steadily pushed up the dollar&#8217;s value against major international currencies since election night, signaling confidence in American economic dominance despite Trump&#8217;s <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42436633/trump-has-a-dollar-problem-president-elect-favors-weaker-currency-but-potential-tariffs-might-end-up-strengthening-the-greenback-instead">historically stated preference for a weaker dollar</a>. &#8220;The most straightforward judgments come from currency traders, who are betting the dollar will remain mighty,&#8221; The Economist said. Meanwhile, the Mexican and Canadian currencies have declined amid concerns over potential 25% tariffs on their exports.
Since Trump&#8217;s election, U.S. stock markets have outperformed global competitors, rising 3%, while European, Japanese and Canadian markets remain stagnant at late-2022 levels.&nbsp;
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
Technology and financial sectors have also seen gains, buoyed by expectations of reduced regulation. However, industries seemingly aligned with Trump&#8217;s policy priorities have struggled. Despite his pro-drilling stance, energy stocks remain constrained by low oil prices. Real estate has suffered from rising borrowing costs, while materials companies face headwinds from potential import tariffs.
The Treasury bond market is a key concern for investors. Ten-year yields have climbed to 4.6% from 3.6% in September, with roughly 80% of the increase stemming from rising term premiums – the extra yield investors demand for potential risks like inflation or unsustainable borrowing. Consumer discretionary companies like Amazon and Tesla have emerged as clear market winners, benefiting from expectations of extended personal income tax cuts. Meanwhile, traditional energy sector stocks have slipped despite Trump&#8217;s pro-drilling stance, with production constrained by low oil prices rather than drilling permissions.
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Market analysts and fund managers interviewed by The Economist expect new tariffs but remain uncertain about potential retaliatory measures from trading partners. While few anticipate massive deportations, concerns persist about inflation risks from <a href="https://www.benzinga.com/startups/24/11/41722059/trumps-deportation-plan-faces-criticism-as-taxpayers-shoulder-the-billions-while-big-business-stands">stricter immigration policies</a>.&nbsp;
The federal deficit, currently at 6.4% of GDP, remains a worry despite hopes that fiscal conservatives in Congress and Trump&#8217;s economic team will maintain discipline.
As Wall Street braces for Inauguration Day, bond traders&#8217; growing unease could force Trump to balance his ambitious economic agenda with the market forces that have historically constrained presidential power.
 Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

'The Dollar Will Remain Mighty': Investors Double Down On Trump's Economic Gambit

ASML Holding's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NYSE">ASML</a>) short percent of float has risen 7.69% since its last report. The company recently reported that it has 1.49 million shares sold short, which is 0.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.03 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>ASML Holding Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434813_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for ASML Holding has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing ASML Holding's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, ASML Holding's peer group average for short interest as a percentage of float is 8.96%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ASML

Peering Into ASML Holding's Recent Short Interest

Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) has outperformed the market over the past 5 years by 16.42% on an annualized basis producing an average annual return of 28.9%. Currently, Tenet Healthcare has a market capitalization of $12.36 billion. 
Buying $1000 In THC: If an investor had bought $1000 of THC stock 5 years ago, it would be worth $3,566.42 today based on a price of $130.00 for THC at the time of writing.
<h3>Tenet Healthcare's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736434812_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Tenet Healthcare 5 Years Ago Would Be Worth Today

Tracking Baker Brothers Portfolio - Q3 2024 Update

Chardan initiated coverage of Stoke Therapeutics (STOK) with a Buy rating and $24 price target The firm cites the potential of the company's lead a...

Stoke Therapeutics initiated with a Buy at Chardan

GeneDx ($WGS) is among the best performing small cap stocks for 2024, posting over 2600% gain. The company analyzes the complete DNA of a person, a...

GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth

Stoke Therapeutics (STOK) announced alignment with global regulatory agencies on the design of the company's Phase 3 EMPEROR study of zorevunersen ...

Stoke Therapeutics finalizes EMPEROR study program with regulatory agencies

An announcement from Stoke Therapeutics ( ($STOK) ) is now available. Stoke Therapeutics has secured alignment with global regulatory agencies for ...

Stoke Therapeutics Gains Regulatory Alignment for Phase 3 Study

Stoke Therapeutics to initiate late-stage study for the treatment of Dravet syndrome

Analyst Joseph Stringer from Needham maintained a Buy rating on Stoke Therapeutics (STOK – Research Report) and keeping the price target at $22.00....

Buy Rating on Stoke Therapeutics Driven by Promising Phase 3 Trial and Financial Stability

Chardan keeps a Buy rating and $24 price target on Stoke Therapeutics (STOK) after the company provided a "long-awaited" update for its Phase 3 stu...

Stoke Therapeutics negative reaction after STK-001 update overdone, says Chardan

Stoke Therapeutics (STOK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew Fein from ...

Stoke Therapeutics' Promising Potential: Buy Rating Backed by Strong Phase 3 Trial Design and Positive Early Results

Leerink Partners analyst Marc Goodman has maintained their bullish stance on STOK stock, giving a Buy rating yesterday. Marc Goodman's rating is ba...

Positive Outlook on Stoke Therapeutics: Strategic Alignment and Promising Data Reinforce Long-Term Growth Potential

ABCL

ACAD

ALGS

ALKS

ARGNF

ARGX

AVTE

BCYC

BEIGF

BGNE

BIIB

BMEA

CERS

DNLI

EWTX

GLUE

HOOK

IGMS

IMCR

IMTX

INCY

INSM

KALA

KNSA

KYMR

MDGL

NRIX

PRAX

RARE

REPL

RVMD

RYTM

SGMT

SMMT

STOK

TCRX

TRDA

TSVT

VTVT

Press Releases

Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer

Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome

Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

Stoke Therapeutics Announces Plans to Present New Data that Support Zorevunersen as Potentially the First Disease-Modifying Medicine for Dravet Syndrome at the American Epilepsy Society 2024 Annual Meeting

Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

Stoke Therapeutics Presents New Open-Label Extension (OLE) Study Data That Further Support the Potential for Zorevunersen as a Disease-Modifying Medicine for the Treatment of Dravet Syndrome

Stoke Therapeutics to Host Webcast to Discuss Successful Global Regulatory Alignment for a Phase 3 Study of Zorevunersen as Potentially the First Disease Modifying Medicine for Dravet Syndrome

Stoke Therapeutics Announces Alignment with Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen as Potentially the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome

Stoke Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Comments

Stoke Therapeutics

Stoke Therapeutics (STOK) オプション

Stoke Therapeutics (NASDAQ:STOK) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル